Børsen
On Monday morning, Genmab made an offer to purchase the Dutch company Merus for nearly 51 billion Danish kroner. With this acquisition, Genmab’s CEO, Jan van de Winkel, can carry out the transformation of the company that has always been planned.
Get full access to Danish News in English
Gain exclusive access to daily news updates in English pertaining to Denmark with a Ritzau News subscription.
Already a subscriber?